Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS-24 and SINUS-52

被引：17

作者：

Bachert, Claus ^{[1
,2
,3
,14
]}

Khan, Asif H. H. ^{[4
]}

Lee, Stella E. E. ^{[5
]}

Hopkins, Claire ^{[6
]}

Peters, Anju T. T. ^{[7
,8
]}

Fokkens, Wytske ^{[9
]}

Praestgaard, Amy ^{[10
]}

Radwan, Amr ^{[11
]}

Nash, Scott ^{[12
]}

Jacob-Nara, Juby A. A. ^{[13
]}

Deniz, Yamo ^{[12
]}

Rowe, Paul J. J. ^{[13
]}

机构：

[1] Univ Hosp Munster, Munster, Germany

[2] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China

[3] Stockholm Univ, Karolinska Hosp, Stockholm, Sweden

[4] Sanofi, Chilly Mazarin, France

[5] Harvard Med Sch, Brigham & Womens Hosp, Div Otolaryngol Head & Neck Surg, Boston, MA USA

[6] Guys & St Thomas Hosp, London, England

[7] Northwestern Univ, Feinberg Sch Med, Allergy Immunol Div, Chicago, IL USA

[8] Northwestern Univ, Sinus & Allergy Ctr, Feinberg Sch Med, Chicago, IL USA

[9] Acad Med Ctr, Amsterdam, Netherlands

[10] Sanofi, Cambridge, MA USA

[11] Regeneron Pharmaceut Inc, Uxbridge, England

[12] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[13] Sanofi, Bridgewater, NJ USA

[14] Univ Hosp Munster, Dept Otorhinolaryngol Head & Neck Surg, Munster, Germany

来源：

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY | 2024年 / 14卷 / 03期

关键词：

chronic rhinosinusitis; medical therapy of chronic rhinosinusitis; paranasal sinus diseases; patient-reported outcome measure;

D O I：

10.1002/alr.23249

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

BackgroundThis post hoc analysis of the international SINUS-24/-52 trials (NCT02912468/NCT02898454) aimed to assess dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polyps (CRSwNP) according to different definitions of type 2 inflammatory signature. MethodsSix definitions of type 2 inflammation were used: & GE;150 eosinophils/& mu;L or total immunoglobulin E (IgE) & GE;100 IU/mL with a coexisting type 2 condition; & GE;150 eosinophils/& mu;L or total IgE & GE;100 IU/mL; & GE;150 eosinophils/& mu;L; & GE;250 eosinophils/& mu;L or total IgE & GE;100 IU/mL; coexisting asthma or & GE;300 eosinophils/& mu;L; presence of a coexisting type 2 condition. Odds ratios (ORs; dupilumab vs. placebo) for achieving clinically meaningful improvement (& GE;1 point) from baseline to week 24 (pooled SINUS-24/-52) and week 52 (SINUS-52) were calculated for nasal polyp score (NPS; range 0-8), nasal congestion/obstruction score (NC; 0-3), and loss of smell score (LoS; 0-3). ResultsAt baseline (n = 724), most patients displayed a type 2 inflammatory signature across definitions (64.2%-95.3%). At week 24, ORs for clinically meaningful improvement ranged from 11.9 to 14.9 for NPS across type 2 definitions, 6.5-9.6 for NC, and 12.2-17.8 for LoS (all p < 0.0001). OR ranges were similar or greater at week 52: 19.0-36.6, 7.6-12.1, and 9.2-33.5, respectively (all p < 0.0001). ConclusionMost patients with CRSwNP in the SINUS study had type 2 inflammation. Dupilumab demonstrated robust efficacy across definitions of type 2 inflammation, consistent with its profile as an inhibitor of Interleukin-4 and Interleukin-13 signaling, key and central drivers of type 2 inflammation in CRSwNP. KEY POINTSThis study assessed type 2 inflammation prevalence and dupilumab efficacy in chronic rhinosinusitis with nasal polyps according to algorithm-defined type 2 inflammationDupilumab efficacy was similar across all type 2 definitions

引用

页码：668 / 678

页数：11

共 19 条

[1] EAACI Biologicals Guidelines-Recommendations for severe asthma [J].

Agache, Ioana ;

Akdis, Cezmi ;

Akdis, Mubeccel ;

Canonica, Giorgio Walter ;

Casale, Thomas ;

Chivato, Tomas ;

Corren, Jonathan ;

Chu, Derek K. ;

Del Giacco, Stefano ;

Eiwegger, Thomas ;

Flood, Breda ;

Firinu, Davide ;

Gern, James E. ;

Hamelmann, Eckard ;

Hanania, Nicola ;

Hernandez-Martin, Irene ;

Knibb, Rebeca ;

Makela, Mika ;

Nair, Parameswaran ;

O'Mahony, Liam ;

Papadopoulos, Nikolaos G. ;

Papi, Alberto ;

Park, Hae-Sim ;

Perez de Llano, Luis ;

Pfaar, Oliver ;

Quirce, Santiago ;

Sastre, Joaquin ;

Shamji, Mohamed ;

Schwarze, Jurgen ;

Palomares, Oscar ;

Jutel, Marek .

ALLERGY, 2021, 76 (01) :14-44

[2] EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management [J].

Bachert, Claus ;

Han, Joe K. ;

Wagenmann, Martin ;

Hosemann, Werner ;

Lee, Stella E. ;

Backer, Vibeke ;

Mullol, Joaquim ;

Gevaert, Philippe ;

Klimek, Ludger ;

Prokopakis, Emanuel ;

Knill, Andrew ;

Cavaliere, Carlo ;

Hopkins, Claire ;

Hellings, Peter .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (01) :29-36

[3]

Bachert C, 2020, J ALLERGY CLIN IMMUN, V145, pAB185

[4] Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials [J].

Bachert, Claus ;

Han, Joseph K. ;

Desrosiers, Martin ;

Hellings, Peter W. ;

Amin, Nikhil ;

Lee, Stella E. ;

Mullol, Joaquim ;

Greos, Leon S. ;

Bosso, John V. ;

Laidlaw, Tanya M. ;

Cervin, Anders U. ;

Maspero, Jorge F. ;

Hopkins, Claire ;

Olze, Heidi ;

Canonica, G. Walter ;

Paggiaro, Pierluigi ;

Cho, Seong H. ;

Fokkens, Wytske J. ;

Fujieda, Shigeharu ;

Zhang, Mei ;

Lu, Xin ;

Fan, Chunpeng ;

Draikiwicz, Steven ;

Kamat, Siddhesh A. ;

Khan, Asif ;

Pirozzi, Gianluca ;

Patel, Naimish ;

Graham, Neil M. H. ;

Ruddy, Marcella ;

Staudinger, Heribert ;

Weinreich, David ;

Stahl, Neil ;

Yancopoulos, George D. ;

Mannent, Leda P. .

LANCET, 2019, 394 (10209) :1638-1650

[5] Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment [J].

De Corso, Eugenio ;

Settimi, Stefano ;

Montuori, Claudio ;

Corbo, Marco ;

Passali, Giulio Cesare ;

Porru, Davide Paolo ;

Lo Verde, Simone ;

Spanu, Camilla ;

Penazzi, Daniele ;

Di Bella, Giuseppe Alberto ;

Nucera, Eleonora ;

Bonini, Matteo ;

Paludetti, Gaetano ;

Galli, Jacopo .

JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)

[6] European Position Paper on Rhinosinusitis and Nasal Polyps 2020 [J].

Fokkens, Wytske J. ;

Lund, Valerie J. ;

Hopkins, Claire ;

Hellings, Peter W. ;

Kern, Robert ;

Reitsma, Sietze ;

Toppila-Salmi, Sanna ;

Bernal-Sprekelsen, Manuel ;

Mullol, Joaquim ;

Alobid, Isam ;

Anselmo-Lima, Wilma Terezinha ;

Bachert, Claus ;

Baroody, Fuad ;

von Buchwald, Christian ;

Cervin, Anders ;

Cohen, Noam ;

Constantinidis, Jannis ;

De Gabory, Ludovic ;

Desrosiers, Martin ;

Diamant, Zuzana ;

Douglas, Richard G. ;

Gevaert, Philippe H. ;

Hafner, Anita ;

Harvey, Richard J. ;

Joos, Guy F. ;

Kalogjera, Livije ;

Knill, Andrew ;

Kocks, Janwillem H. ;

Landis, Basile N. ;

Limpens, Jacqueline ;

Lebeer, Sarah ;

Lourenco, Olga ;

Matricardi, Paolo M. ;

Meco, Cem ;

O'Mahony, Liam ;

Philpott, Carl M. ;

Ryan, Dermot ;

Schlosser, Rodney ;

Senior, Brent ;

Smith, Timothy L. ;

Teeling, Thijs ;

Tomazic, Peter Valentin ;

Wang, De Yun ;

Wang, Dehui ;

Zhang, Luo ;

Agius, Adrian M. ;

Ahlstrom-Emanuelsson, Cecilia ;

Alabri, Rashid ;

Albu, Silviu ;

Alhabash, Saied .

RHINOLOGY, 2020, 58 :1-464

[7]

Global Initiative for Asthma, GLOB STRAT ASTHM MAN

[8] Estimating Clinically Meaningful Change of Efficacy Outcomes in Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyposis [J].

Han, Joseph K. ;

Bachert, Claus ;

Lee, Stella E. ;

Hopkins, Claire ;

Heffler, Enrico ;

Hellings, Peter W. ;

Peters, Anju T. ;

Kamat, Siddhesh ;

Whalley, Diane ;

Qin, Shanshan ;

Nelson, Lauren ;

Siddiqui, Shahid ;

Khan, Asif H. ;

Li, Yongtao ;

Mannent, Leda P. ;

Guillemin, Isabelle ;

Chuang, Chien-Chia .

LARYNGOSCOPE, 2022, 132 (02) :265-271

[9] Psychometric validity of the 22-item Sinonasal Outcome Test [J].

Hopkins, C. ;

Gillett, S. ;

Slack, R. ;

Lund, V. J. ;

Browne, J. P. .

CLINICAL OTOLARYNGOLOGY, 2009, 34 (05) :447-454

[10] Dupilumab (Dupixent(R)) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany [J].

Jansen, Florian ;

Becker, Benjamin ;

Eden, Jordis K. ;

Breda, Philippe C. ;

Hot, Amra ;

Oqueka, Tim ;

Betz, Christian S. ;

Hoffmann, Anna S. .

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2023, 280 (04) :1741-1755

← 1 2 →